News
Explore market and company news with sources and timestamps.
- Current data
- Each article’s publication time
- Next data
- New data per source
- Expected availability
- No confirmed schedule
Topic
Topics are assigned from article titles and may differ from the publisher’s categories.
News coverage is partial. Showing available news.
진양제약, 고지혈증 치료제 'JY501' 임상 본격화 (new window)
Other newswww.press9.krKORead supplied summary — 진양제약, 고지혈증 치료제 'JY501' 임상 본격화
고지혈증 복합제 외에도 당뇨병 치료 개량신약 'JY303'의 임상 3상을 추진하고 있다. 올해 초 동아에스티 출신 박희범 전무를 영입해 신약개발·허가관리 역량을 보강했다. 사진/진양제약
Summary supplied by the source. Open the original for the full article.